Erratum to: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases
- Arbi Pecani†1,
- Cristiano Alessandri†1Email author,
- Francesca Romana Spinelli1,
- Roberta Priori1,
- Valeria Riccieri1,
- Manuela Di Franco1,
- Fulvia Ceccarelli1,
- Tania Colasanti1,
- Monica Pendolino1,
- Riccardo Mancini1,
- Simona Truglia1,
- Cristiana Barbati1,
- Marta Vomero1,
- Danilo Sabatinelli1,
- Francesca Morello1,
- Guido Valesini1 and
- Fabrizio Conti1
https://doi.org/10.1186/s13075-016-1205-9
© The Author(s). 2016
Received: 7 December 2016
Accepted: 8 December 2016
Published: 16 December 2016
The original article was published in Arthritis Research & Therapy 2016 18:276
Results
Anti-CarP antibodies were detected in 117 patients with RA (37.9%), ACPA in 190 patients (61.4%) and RF in 202 patients (65.3%). Two (2.04%) of the NHS were positive for anti-CarP, one NHS (1.02%) was positive for ACPA and three NHS were positive for RF (3.06%). Among disease controls, anti-CarP antibodies were detected in 33 patients (16.5%), ACPA in 29 patients (14.5%) and RF in 64 patients (32%). In particular, 16.8% of patients with systemic lupus erythematosus and 31.1% of patients with Sjögren syndrome were positive for anti-CarP. The sensitivity of anti-CarP, ACPA and RF was 46.8, 61.8 and 64.4%, respectively and specificity was 91.95, 89.93 and 76.51%, respectively.
Erratum
Prevalence of anti-CarP, ACPA and RF in RA patients, disease controls and healthy subjects
Disease (No of patients) | Anti-CarP positive n, (%) | ACPA positive n, (%) | RF positive n, (%) |
|---|---|---|---|
RA (309) | 117 (37.9) | 190 (61.4) | 202 (65.3) |
NHS (98) | 2 (2.04) | 1 (1.02) | 3 (3.06) |
SLE (83) | 14 (16.8) | 15 (18.07) | 19 (22.8) |
SS (45) | 14 (31.1) | 11 (24.4) | 23 (51.1) |
SSc (51) | 3 (5.8) | 1 (1.9) | 18 (35.2) |
OP (21) | 2 (9.5) | 2 (9.5) | 4 (19.04) |
Notes
Declarations
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Authors’ Affiliations
Reference
- Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Franco MD, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, et al. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Arthritis Res Ther. 2016;18:276. doi:10.1186/s13075-016-1173-0.View ArticlePubMedPubMed CentralGoogle Scholar
